Related Articles
mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review)
ARID1A gene mutation in ovarian and endometrial cancers (Review)
Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
Histone deacetylase inhibitors: Apoptotic effects and clinical implications (Review)
Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review)